Alcohol's Impact on Decision-Making in PTSD
(PACS Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores how alcohol affects decision-making in people with PTSD, particularly when they face choices involving potential risks and rewards. Researchers aim to determine if PTSD increases the risk of developing alcohol use disorders due to altered decision-making. Participants will consume either alcohol or a placebo (a non-alcoholic version) to examine these effects. The trial seeks individuals aged 21-60 who have PTSD and have consumed at least a few drinks on two occasions in the past year. As an unphased trial, this study offers a unique opportunity to enhance understanding of PTSD and alcohol use, potentially benefiting future treatments.
Will I have to stop taking my current medications?
The trial requires that participants have been taking their medications for more than 4 weeks, meaning you must be stable on your current medications to participate.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that many people with PTSD often drink alcohol. One study found a close link between PTSD symptoms and increased alcohol use. Another study suggested that treating PTSD and alcohol use disorder together can significantly reduce PTSD symptoms. This indicates that people with PTSD might drink to cope, leading to harmful drinking habits.
Regarding safety, studies on alcohol use in PTSD patients regularly monitor participants' alcohol consumption and its effects on thinking and coordination. Although these studies do not focus specifically on safety, they show that researchers closely monitor alcohol use.
Overall, there is a known connection between PTSD and alcohol use, but detailed safety information on alcohol's effects in these studies remains limited. Participants should consider this when deciding whether to join a trial involving alcohol consumption.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it explores how alcohol affects decision-making in individuals with PTSD, which is a new angle compared to traditional treatments like therapy or medication that focus on reducing symptoms. This study uses an innovative approach by incorporating an "approach-avoidance" technique alongside an alcohol challenge, allowing researchers to observe changes in decision-making behavior in real-time. The trial aims to uncover how alcohol influences cognitive processes in PTSD, potentially leading to more targeted strategies that address decision-making impairments, which are not directly tackled by current standard treatments.
What evidence suggests that this trial's treatments could be effective for PTSD and alcohol use disorders?
This trial will compare the effects of alcohol and a placebo on decision-making in individuals with PTSD. Research has shown that people with PTSD often struggle more with alcohol use than those without PTSD. Alcohol can influence decision-making in people with PTSD, particularly in challenging situations where they must choose between a possible reward and a potential threat. This can lead to risky behaviors, such as drinking more despite knowing the harm. Some studies suggest that treating PTSD and alcohol problems together can reduce PTSD symptoms and assist with drinking issues. However, no single treatment works best for both conditions. Understanding how alcohol impacts decision-making in PTSD might aid in developing better treatment strategies.23678
Who Is on the Research Team?
Elizabeth Lippard, PhD
Principal Investigator
University of Texas at Austin
Josh Cisler, PhD
Principal Investigator
University of Texas at Austin
Are You a Good Fit for This Trial?
This trial is for adults aged 21-60 with PTSD who have had at least two occasions in the past year where they consumed a significant amount of alcohol (4 drinks for men, 3 for women). They must be diagnosed with PTSD through an interview.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo placebo-controlled alcohol administration procedures to investigate the effects of acute alcohol on approach-avoidance decision-making
Follow-up
Participants are monitored for changes in alcohol use and symptoms of AUDs over a one-year period
What Are the Treatments Tested in This Trial?
Interventions
- Approach-Avoidance and Alcohol Challenge Study
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Texas at Austin
Lead Sponsor